pharmaceutical daily

Previously announced FDA approval of IBRANCE® (palbociclib) for the treatment of men with metastatic breast cancer based in part on…

GUILFORD, Conn.–(BUSINESS WIRE)–BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI), ), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3 TM platform technology for the…

ROCKVILLE, Md.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/allergies?src=hash" target="_blank"gt;#allergieslt;/agt;–Immunomic Therapeutics, Inc. (ITI), a privately held, Maryland-based biotechnology company, announced today that the company will…

– Novel vector, 4D-C102, demonstrates superior performance compared to commonly used AAV1, AAV8, and AAV9 – – Fabry product candidate,…

MARIETTA, Ohio–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/AAGP?src=hash" target="_blank"gt;#AAGPlt;/agt;–ProtoKinetix, Incorporated (www.protokinetix.com) (the “Company” or “ProtoKinetix”) (OTCQB:PKTX) today announces that it will hold the first…

NASHVILLE, Tenn.–(BUSINESS WIRE)–Today, Sarah Cannon announced that it will present its latest cancer research insights through more than 100 abstracts…

– Canntab Makes Progress Towards Becoming Revenue-Generating in 2019 – TORONTO–(BUSINESS WIRE)–Canntab Therapeutics Limited (CSE:PILL.CN) (OTCQX:CTABF) (FRA:TBF1.F) (the “Company” or “Canntab“), the leading…

ARLINGTON, Va.–(BUSINESS WIRE)–Battelle’s Principal Research Scientist-Biologist Vivian Smith has been named the 2019 recipient of the Dr. Billy Richardson Young…

Grant will support development of a new treatment for retinitis pigmentosa CLEVELAND–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/BioMotiv?src=hash" target="_blank"gt;#BioMotivlt;/agt;–OptiKira, LLC, a privately-held biotechnology company…

TOKYO–(BUSINESS WIRE)–Modulus Discovery, Inc. (CEO: S. Roy Kimura, Ph.D., “Modulus”), an early stage global biopharmaceutical company, announced today the signing…